American Samoa
Guam
Hawaii
Northern Mariana Islands
01212 - A and B MAC
American Samoa
Guam
Hawaii
Northern Mariana Islands
01311 - A and B MAC
Nevada
01312 - A and B MAC
Nevada
01911 - A and B MAC
American Samoa
California - Entire State
Guam
Hawaii
Nevada
Northern Mariana Islands
Article Information
Article ID Number: A55001 Status: A-Approved
Article Title: Billing and Coding: Urine Drug Testing
Original Article Effective Date:
06/28/2016
Revision Effective Date:
10/01/2024
Article Text:
This article contains coding that complements the Local Coverage Determination (LCD) for Urine Drug Testing.
Coding Guidelines:
Procedure codes may be subject to National Correct Coding Initiative (NCCI) edits or OPPS packaging edits. Refer to NCCI and OPPS requirements prior to billing Medicare.
For services requiring a referring/ordering physician, the name and NPI of the referring/ordering physician must be reported on the claim.
A claim submitted without a valid ICD-10-CM diagnosis code will be returned to the provider as an incomplete claim under Section 1833(e) of the Social Security Act.
The diagnosis code(s) must best describe the patient's condition for which the service was performed. For diagnostic tests, report the result of the test if known; otherwise the symptoms prompting the performance of the test should be reported.
Coding Information
Bill Type Codes:
Contractors may specify Bill Types to help providers identify those Bill Types typically used to report this service. Absence of a Bill Type does not guarantee that the policy does not apply to that Bill Type. Complete absence of all Bill Types indicates that coverage is not influenced by Bill Type and the policy should be assumed to apply equally to all claims.
CPT/HCPCS Codes:
Group 1 Paragraph:
Group 1 CPT Codes:
80305
DRUG TEST(S), PRESUMPTIVE, ANY NUMBER OF DRUG CLASSES, ANY NUMBER OF DEVICES OR PROCEDURES; CAPABLE OF BEING READ BY DIRECT OPTICAL OBSERVATION ONLY (EG, UTILIZING IMMUNOASSAY [EG, DIPSTICKS, CUPS, CARDS, OR CARTRIDGES]), INCLUDES SAMPLE VALIDATION WHEN PERFORMED, PER DATE OF SERVICE
80306
DRUG TEST(S), PRESUMPTIVE, ANY NUMBER OF DRUG CLASSES, ANY NUMBER OF DEVICES OR PROCEDURES; READ BY INSTRUMENT ASSISTED DIRECT OPTICAL OBSERVATION (EG, UTILIZING IMMUNOASSAY [EG, DIPSTICKS, CUPS, CARDS, OR CARTRIDGES]), INCLUDES SAMPLE VALIDATION WHEN PERFORMED, PER DATE OF SERVICE
80307
DRUG TEST(S), PRESUMPTIVE, ANY NUMBER OF DRUG CLASSES, ANY NUMBER OF DEVICES OR PROCEDURES; BY INSTRUMENT CHEMISTRY ANALYZERS (EG, UTILIZING IMMUNOASSAY [EG, EIA, ELISA, EMIT, FPIA, IA, KIMS, RIA]), CHROMATOGRAPHY (EG, GC, HPLC), AND MASS SPECTROMETRY EITHER WITH OR WITHOUT CHROMATOGRAPHY, (EG, DART, DESI, GC-MS, GC-MS/MS, LC-MS, LC-MS/MS, LDTD, MALDI, TOF) INCLUDES SAMPLE VALIDATION WHEN PERFORMED, PER DATE OF SERVICE
G0480
DRUG TEST(S), DEFINITIVE, UTILIZING (1) DRUG IDENTIFICATION METHODS ABLE TO IDENTIFY INDIVIDUAL DRUGS AND DISTINGUISH BETWEEN STRUCTURAL ISOMERS (BUT NOT NECESSARILY STEREOISOMERS), INCLUDING, BUT NOT LIMITED TO GC/MS (ANY TYPE, SINGLE OR TANDEM) AND LC/MS (ANY TYPE, SINGLE OR TANDEM AND EXCLUDING IMMUNOASSAYS (E.G., IA, EIA, ELISA, EMIT, FPIA) AND ENZYMATIC METHODS (E.G., ALCOHOL DEHYDROGENASE)), (2) STABLE ISOTOPE OR OTHER UNIVERSALLY RECOGNIZED INTERNAL STANDARDS IN ALL SAMPLES (E.G., TO CONTROL FOR MATRIX EFFECTS, INTERFERENCES AND VARIATIONS IN SIGNAL STRENGTH), AND (3) METHOD OR DRUG-SPECIFIC CALIBRATION AND MATRIX-MATCHED QUALITY CONTROL MATERIAL (E.G., TO CONTROL FOR INSTRUMENT VARIATIONS AND MASS SPECTRAL DRIFT); QUALITATIVE OR QUANTITATIVE, ALL SOURCES, INCLUDES SPECIMEN VALIDITY TESTING, PER DAY; 1-7 DRUG CLASS(ES), INCLUDING METABOLITE(S) IF PERFORMED
G0481
DRUG TEST(S), DEFINITIVE, UTILIZING (1) DRUG IDENTIFICATION METHODS ABLE TO IDENTIFY INDIVIDUAL DRUGS AND DISTINGUISH BETWEEN STRUCTURAL ISOMERS (BUT NOT NECESSARILY STEREOISOMERS), INCLUDING, BUT NOT LIMITED TO GC/MS (ANY TYPE, SINGLE OR TANDEM) AND LC/MS (ANY TYPE, SINGLE OR TANDEM AND EXCLUDING IMMUNOASSAYS (E.G., IA, EIA, ELISA, EMIT, FPIA) AND ENZYMATIC METHODS (E.G., ALCOHOL DEHYDROGENASE)), (2) STABLE ISOTOPE OR OTHER UNIVERSALLY RECOGNIZED INTERNAL STANDARDS IN ALL SAMPLES (E.G., TO CONTROL FOR MATRIX EFFECTS, INTERFERENCES AND VARIATIONS IN SIGNAL STRENGTH), AND (3) METHOD OR DRUG-SPECIFIC CALIBRATION AND MATRIX-MATCHED QUALITY CONTROL MATERIAL (E.G., TO CONTROL FOR INSTRUMENT VARIATIONS AND MASS SPECTRAL DRIFT); QUALITATIVE OR QUANTITATIVE, ALL SOURCES, INCLUDES SPECIMEN VALIDITY TESTING, PER DAY; 8-14 DRUG CLASS(ES), INCLUDING METABOLITE(S) IF PERFORMED
G0482
DRUG TEST(S), DEFINITIVE, UTILIZING (1) DRUG IDENTIFICATION METHODS ABLE TO IDENTIFY INDIVIDUAL DRUGS AND DISTINGUISH BETWEEN STRUCTURAL ISOMERS (BUT NOT NECESSARILY STEREOISOMERS), INCLUDING, BUT NOT LIMITED TO GC/MS (ANY TYPE, SINGLE OR TANDEM) AND LC/MS (ANY TYPE, SINGLE OR TANDEM AND EXCLUDING IMMUNOASSAYS (E.G., IA, EIA, ELISA, EMIT, FPIA) AND ENZYMATIC METHODS (E.G., ALCOHOL DEHYDROGENASE)), (2) STABLE ISOTOPE OR OTHER UNIVERSALLY RECOGNIZED INTERNAL STANDARDS IN ALL SAMPLES (E.G., TO CONTROL FOR MATRIX EFFECTS, INTERFERENCES AND VARIATIONS IN SIGNAL STRENGTH), AND (3) METHOD OR DRUG-SPECIFIC CALIBRATION AND MATRIX-MATCHED QUALITY CONTROL MATERIAL (E.G., TO CONTROL FOR INSTRUMENT VARIATIONS AND MASS SPECTRAL DRIFT); QUALITATIVE OR QUANTITATIVE, ALL SOURCES, INCLUDES SPECIMEN VALIDITY TESTING, PER DAY; 15-21 DRUG CLASS(ES), INCLUDING METABOLITE(S) IF PERFORMED
G0483
DRUG TEST(S), DEFINITIVE, UTILIZING (1) DRUG IDENTIFICATION METHODS ABLE TO IDENTIFY INDIVIDUAL DRUGS AND DISTINGUISH BETWEEN STRUCTURAL ISOMERS (BUT NOT NECESSARILY STEREOISOMERS), INCLUDING, BUT NOT LIMITED TO GC/MS (ANY TYPE, SINGLE OR TANDEM) AND LC/MS (ANY TYPE, SINGLE OR TANDEM AND EXCLUDING IMMUNOASSAYS (E.G., IA, EIA, ELISA, EMIT, FPIA) AND ENZYMATIC METHODS (E.G., ALCOHOL DEHYDROGENASE)), (2) STABLE ISOTOPE OR OTHER UNIVERSALLY RECOGNIZED INTERNAL STANDARDS IN ALL SAMPLES (E.G., TO CONTROL FOR MATRIX EFFECTS, INTERFERENCES AND VARIATIONS IN SIGNAL STRENGTH), AND (3) METHOD OR DRUG-SPECIFIC CALIBRATION AND MATRIX-MATCHED QUALITY CONTROL MATERIAL (E.G., TO CONTROL FOR INSTRUMENT VARIATIONS AND MASS SPECTRAL DRIFT); QUALITATIVE OR QUANTITATIVE, ALL SOURCES, INCLUDES SPECIMEN VALIDITY TESTING, PER DAY; 22 OR MORE DRUG CLASS(ES), INCLUDING METABOLITE(S) IF PERFORMED
G0659
DRUG TEST(S), DEFINITIVE, UTILIZING DRUG IDENTIFICATION METHODS ABLE TO IDENTIFY INDIVIDUAL DRUGS AND DISTINGUISH BETWEEN STRUCTURAL ISOMERS (BUT NOT NECESSARILY STEREOISOMERS), INCLUDING BUT NOT LIMITED TO GC/MS (ANY TYPE, SINGLE OR TANDEM) AND LC/MS (ANY TYPE, SINGLE OR TANDEM), EXCLUDING IMMUNOASSAYS (E.G., IA, EIA, ELISA, EMIT, FPIA) AND ENZYMATIC METHODS (E.G., ALCOHOL DEHYDROGENASE), PERFORMED WITHOUT METHOD OR DRUG-SPECIFIC CALIBRATION, WITHOUT MATRIX-MATCHED QUALITY CONTROL MATERIAL, OR WITHOUT USE OF STABLE ISOTOPE OR OTHER UNIVERSALLY RECOGNIZED INTERNAL STANDARD(S) FOR EACH DRUG, DRUG METABOLITE OR DRUG CLASS PER SPECIMEN; QUALITATIVE OR QUANTITATIVE, ALL SOURCES, INCLUDES SPECIMEN VALIDITY TESTING, PER DAY, ANY NUMBER OF DRUG CLASSES
ICD-10 Codes That Are Covered
E87.20
Acidosis, unspecified
E87.21
Acute metabolic acidosis
E87.22
Chronic metabolic acidosis
E87.29
Other acidosis
F10.11
Alcohol abuse, in remission
F10.20
Alcohol dependence, uncomplicated
F11.11
Opioid abuse, in remission
F11.20
Opioid dependence, uncomplicated
F11.220
Opioid dependence with intoxication, uncomplicated
F11.221
Opioid dependence with intoxication delirium
F11.222
Opioid dependence with intoxication with perceptual disturbance
F11.229
Opioid dependence with intoxication, unspecified
F11.23
Opioid dependence with withdrawal
F11.24
Opioid dependence with opioid-induced mood disorder
F11.250
Opioid dependence with opioid-induced psychotic disorder with delusions
F11.251
Opioid dependence with opioid-induced psychotic disorder with hallucinations
F11.259
Opioid dependence with opioid-induced psychotic disorder, unspecified
F11.281
Opioid dependence with opioid-induced sexual dysfunction
F11.282
Opioid dependence with opioid-induced sleep disorder
F11.288
Opioid dependence with other opioid-induced disorder
F11.29
Opioid dependence with unspecified opioid-induced disorder
F12.11
Cannabis abuse, in remission
F13.11
Sedative, hypnotic or anxiolytic abuse, in remission
F14.11
Cocaine abuse, in remission
F15.11
Other stimulant abuse, in remission
F16.11
Hallucinogen abuse, in remission
F18.10
Inhalant abuse, uncomplicated
F18.11
Inhalant abuse, in remission
F18.120
Inhalant abuse with intoxication, uncomplicated
F18.90
Inhalant use, unspecified, uncomplicated
F19.11
Other psychoactive substance abuse, in remission
F19.20
Other psychoactive substance dependence, uncomplicated
F20.0
Paranoid schizophrenia
F20.1
Disorganized schizophrenia
F20.2
Catatonic schizophrenia
F20.89
Other schizophrenia
F55.0
Abuse of antacids
F55.1
Abuse of herbal or folk remedies
F55.2
Abuse of laxatives
F55.3
Abuse of steroids or hormones
F55.4
Abuse of vitamins
F55.8
Abuse of other non-psychoactive substances
G40.301
Generalized idiopathic epilepsy and epileptic syndromes, not intractable, with status epilepticus
G40.309
Generalized idiopathic epilepsy and epileptic syndromes, not intractable, without status epilepticus
G40.311
Generalized idiopathic epilepsy and epileptic syndromes, intractable, with status epilepticus
G40.319
Generalized idiopathic epilepsy and epileptic syndromes, intractable, without status epilepticus
G40.401
Other generalized epilepsy and epileptic syndromes, not intractable, with status epilepticus
G40.409
Other generalized epilepsy and epileptic syndromes, not intractable, without status epilepticus
G40.411
Other generalized epilepsy and epileptic syndromes, intractable, with status epilepticus
G40.419
Other generalized epilepsy and epileptic syndromes, intractable, without status epilepticus
G40.901
Epilepsy, unspecified, not intractable, with status epilepticus
G40.909
Epilepsy, unspecified, not intractable, without status epilepticus
G40.911
Epilepsy, unspecified, intractable, with status epilepticus
G40.919
Epilepsy, unspecified, intractable, without status epilepticus
G89.29
Other chronic pain
G89.4
Chronic pain syndrome
I44.0
Atrioventricular block, first degree
I44.1
Atrioventricular block, second degree
I44.30
Unspecified atrioventricular block
I45.81
Long QT syndrome
I47.0
Re-entry ventricular arrhythmia
I47.10
Supraventricular tachycardia, unspecified
I47.11
Inappropriate sinus tachycardia, so stated
I47.19
Other supraventricular tachycardia
I47.20
Ventricular tachycardia, unspecified
I47.21
Torsades de pointes
I47.29
Other ventricular tachycardia
I49.2
Junctional premature depolarization
M25.50
Pain in unspecified joint
M47.21
Other spondylosis with radiculopathy, occipito-atlanto-axial region
M47.22
Other spondylosis with radiculopathy, cervical region
M47.23
Other spondylosis with radiculopathy, cervicothoracic region
M47.26
Other spondylosis with radiculopathy, lumbar region
M47.27
Other spondylosis with radiculopathy, lumbosacral region
M47.28
Other spondylosis with radiculopathy, sacral and sacrococcygeal region
M47.811
Spondylosis without myelopathy or radiculopathy, occipito-atlanto-axial region
M47.812
Spondylosis without myelopathy or radiculopathy, cervical region
M47.813
Spondylosis without myelopathy or radiculopathy, cervicothoracic region
M47.816
Spondylosis without myelopathy or radiculopathy, lumbar region
M47.817
Spondylosis without myelopathy or radiculopathy, lumbosacral region
M47.818
Spondylosis without myelopathy or radiculopathy, sacral and sacrococcygeal region
M47.891
Other spondylosis, occipito-atlanto-axial region
M47.892
Other spondylosis, cervical region
M47.893
Other spondylosis, cervicothoracic region
M47.896
Other spondylosis, lumbar region
M47.897
Other spondylosis, lumbosacral region
M47.898
Other spondylosis, sacral and sacrococcygeal region
M51.14
Intervertebral disc disorders with radiculopathy, thoracic region
M51.15
Intervertebral disc disorders with radiculopathy, thoracolumbar region
M51.16
Intervertebral disc disorders with radiculopathy, lumbar region
M51.17
Intervertebral disc disorders with radiculopathy, lumbosacral region
M54.14
Radiculopathy, thoracic region
M54.15
Radiculopathy, thoracolumbar region
M54.16
Radiculopathy, lumbar region
M54.17
Radiculopathy, lumbosacral region
M54.18
Radiculopathy, sacral and sacrococcygeal region
M54.2
Cervicalgia
M54.51
Vertebrogenic low back pain
M54.9
Dorsalgia, unspecified
M60.811
Other myositis, right shoulder
M60.812
Other myositis, left shoulder
M60.821
Other myositis, right upper arm
M60.822
Other myositis, left upper arm
M60.831
Other myositis, right forearm
M60.832
Other myositis, left forearm
M60.841
Other myositis, right hand
M60.842
Other myositis, left hand
M60.851
Other myositis, right thigh
M60.852
Other myositis, left thigh
M60.861
Other myositis, right lower leg
M60.862
Other myositis, left lower leg
M60.871
Other myositis, right ankle and foot
M60.872
Other myositis, left ankle and foot
M60.88
Other myositis, other site
M60.89
Other myositis, multiple sites
M60.9
Myositis, unspecified
M79.10
Myalgia, unspecified site
M79.11
Myalgia of mastication muscle
M79.12
Myalgia of auxiliary muscles, head and neck
M79.18
Myalgia, other site
M79.2
Neuralgia and neuritis, unspecified
M79.7
Fibromyalgia
R40.0
Somnolence
R40.1
Stupor
R40.20
Unspecified coma
R40.2110
Coma scale, eyes open, never, unspecified time
R40.2111
Coma scale, eyes open, never, in the field [EMT or ambulance]
R40.2112
Coma scale, eyes open, never, at arrival to emergency department
R40.2113
Coma scale, eyes open, never, at hospital admission
R40.2114
Coma scale, eyes open, never, 24 hours or more after hospital admission
R40.2120
Coma scale, eyes open, to pain, unspecified time
R40.2121
Coma scale, eyes open, to pain, in the field [EMT or ambulance]
R40.2122
Coma scale, eyes open, to pain, at arrival to emergency department
R40.2123
Coma scale, eyes open, to pain, at hospital admission
R40.2124
Coma scale, eyes open, to pain, 24 hours or more after hospital admission
R40.2210
Coma scale, best verbal response, none, unspecified time
R40.2211
Coma scale, best verbal response, none, in the field [EMT or ambulance]
R40.2212
Coma scale, best verbal response, none, at arrival to emergency department
R40.2213
Coma scale, best verbal response, none, at hospital admission
R40.2214
Coma scale, best verbal response, none, 24 hours or more after hospital admission
R40.2220
Coma scale, best verbal response, incomprehensible words, unspecified time
R40.2221
Coma scale, best verbal response, incomprehensible words, in the field [EMT or ambulance]
R40.2222
Coma scale, best verbal response, incomprehensible words, at arrival to emergency department
R40.2223
Coma scale, best verbal response, incomprehensible words, at hospital admission
R40.2224
Coma scale, best verbal response, incomprehensible words, 24 hours or more after hospital admission
R40.2310
Coma scale, best motor response, none, unspecified time
R40.2311
Coma scale, best motor response, none, in the field [EMT or ambulance]
R40.2312
Coma scale, best motor response, none, at arrival to emergency department
R40.2313
Coma scale, best motor response, none, at hospital admission
R40.2314
Coma scale, best motor response, none, 24 hours or more after hospital admission
R40.2320
Coma scale, best motor response, extension, unspecified time
R40.2321
Coma scale, best motor response, extension, in the field [EMT or ambulance]
R40.2322
Coma scale, best motor response, extension, at arrival to emergency department
R40.2323
Coma scale, best motor response, extension, at hospital admission
R40.2324
Coma scale, best motor response, extension, 24 hours or more after hospital admission
R40.2340
Coma scale, best motor response, flexion withdrawal, unspecified time
R40.2341
Coma scale, best motor response, flexion withdrawal, in the field [EMT or ambulance]
R40.2342
Coma scale, best motor response, flexion withdrawal, at arrival to emergency department
R40.2343
Coma scale, best motor response, flexion withdrawal, at hospital admission
R40.2344
Coma scale, best motor response, flexion withdrawal, 24 hours or more after hospital admission
R40.2A
Nontraumatic coma due to underlying condition
R44.0
Auditory hallucinations
R44.2
Other hallucinations
R44.3
Hallucinations, unspecified
R56.9
Unspecified convulsions
T14.91XA
Suicide attempt, initial encounter
T14.91XD
Suicide attempt, subsequent encounter
T14.91XS
Suicide attempt, sequela
T39.011A
Poisoning by aspirin, accidental (unintentional), initial encounter
T39.012A
Poisoning by aspirin, intentional self-harm, initial encounter
T39.013A
Poisoning by aspirin, assault, initial encounter
T39.014A
Poisoning by aspirin, undetermined, initial encounter
T39.091A
Poisoning by salicylates, accidental (unintentional), initial encounter
T39.092A
Poisoning by salicylates, intentional self-harm, initial encounter
T39.093A
Poisoning by salicylates, assault, initial encounter
T39.094A
Poisoning by salicylates, undetermined, initial encounter
T39.1X1A
Poisoning by 4-Aminophenol derivatives, accidental (unintentional), initial encounter
T39.1X2A
Poisoning by 4-Aminophenol derivatives, intentional self-harm, initial encounter
T39.1X3A
Poisoning by 4-Aminophenol derivatives, assault, initial encounter
T39.1X4A
Poisoning by 4-Aminophenol derivatives, undetermined, initial encounter
T39.2X1A
Poisoning by pyrazolone derivatives, accidental (unintentional), initial encounter
T39.2X2A
Poisoning by pyrazolone derivatives, intentional self-harm, initial encounter
T39.2X3A
Poisoning by pyrazolone derivatives, assault, initial encounter
T39.2X4A
Poisoning by pyrazolone derivatives, undetermined, initial encounter
T39.311A
Poisoning by propionic acid derivatives, accidental (unintentional), initial encounter
T39.312A
Poisoning by propionic acid derivatives, intentional self-harm, initial encounter
T39.313A
Poisoning by propionic acid derivatives, assault, initial encounter
T39.314A
Poisoning by propionic acid derivatives, undetermined, initial encounter
T39.391A
Poisoning by other nonsteroidal anti-inflammatory drugs [NSAID], accidental (unintentional), initial encounter
T39.392A
Poisoning by other nonsteroidal anti-inflammatory drugs [NSAID], intentional self-harm, initial encounter
T39.393A
Poisoning by other nonsteroidal anti-inflammatory drugs [NSAID], assault, initial encounter
T39.394A
Poisoning by other nonsteroidal anti-inflammatory drugs [NSAID], undetermined, initial encounter
T40.0X1A
Poisoning by opium, accidental (unintentional), initial encounter
T40.0X2A
Poisoning by opium, intentional self-harm, initial encounter
T40.0X3A
Poisoning by opium, assault, initial encounter
T40.0X4A
Poisoning by opium, undetermined, initial encounter
T40.1X1A
Poisoning by heroin, accidental (unintentional), initial encounter
T40.1X2A
Poisoning by heroin, intentional self-harm, initial encounter
T40.1X3A
Poisoning by heroin, assault, initial encounter
T40.1X4A
Poisoning by heroin, undetermined, initial encounter
T40.2X1A
Poisoning by other opioids, accidental (unintentional), initial encounter
T40.2X2A
Poisoning by other opioids, intentional self-harm, initial encounter
T40.2X3A
Poisoning by other opioids, assault, initial encounter
T40.2X4A
Poisoning by other opioids, undetermined, initial encounter
T40.3X1A
Poisoning by methadone, accidental (unintentional), initial encounter
T40.3X2A
Poisoning by methadone, intentional self-harm, initial encounter
T40.3X3A
Poisoning by methadone, assault, initial encounter
T40.3X4A
Poisoning by methadone, undetermined, initial encounter
T40.491A
Poisoning by other synthetic narcotics, accidental (unintentional), initial encounter
T40.492A
Poisoning by other synthetic narcotics, intentional self-harm, initial encounter
T40.493A
Poisoning by other synthetic narcotics, assault, initial encounter
T40.494A
Poisoning by other synthetic narcotics, undetermined, initial encounter
T40.601A
Poisoning by unspecified narcotics, accidental (unintentional), initial encounter
T40.602A
Poisoning by unspecified narcotics, intentional self-harm, initial encounter
T40.603A
Poisoning by unspecified narcotics, assault, initial encounter
T40.604A
Poisoning by unspecified narcotics, undetermined, initial encounter
T40.691A
Poisoning by other narcotics, accidental (unintentional), initial encounter
T40.692A
Poisoning by other narcotics, intentional self-harm, initial encounter
T40.693A
Poisoning by other narcotics, assault, initial encounter
T40.694A
Poisoning by other narcotics, undetermined, initial encounter
T40.711A
Poisoning by cannabis, accidental (unintentional), initial encounter
T40.712A
Poisoning by cannabis, intentional self-harm, initial encounter
T40.713A
Poisoning by cannabis, assault, initial encounter
T40.714A
Poisoning by cannabis, undetermined, initial encounter
T40.8X1A
Poisoning by lysergide [LSD], accidental (unintentional), initial encounter
T40.8X2A
Poisoning by lysergide [LSD], intentional self-harm, initial encounter
T40.8X3A
Poisoning by lysergide [LSD], assault, initial encounter
T40.8X4A
Poisoning by lysergide [LSD], undetermined, initial encounter
T40.901A
Poisoning by unspecified psychodysleptics [hallucinogens], accidental (unintentional), initial encounter
T40.902A
Poisoning by unspecified psychodysleptics [hallucinogens], intentional self-harm, initial encounter
T40.903A
Poisoning by unspecified psychodysleptics [hallucinogens], assault, initial encounter
T40.904A
Poisoning by unspecified psychodysleptics [hallucinogens], undetermined, initial encounter
T40.991A
Poisoning by other psychodysleptics [hallucinogens], accidental (unintentional), initial encounter
T40.992A
Poisoning by other psychodysleptics [hallucinogens], intentional self-harm, initial encounter
T40.993A
Poisoning by other psychodysleptics [hallucinogens], assault, initial encounter
T40.994A
Poisoning by other psychodysleptics [hallucinogens], undetermined, initial encounter
T42.0X1A
Poisoning by hydantoin derivatives, accidental (unintentional), initial encounter
T42.0X2A
Poisoning by hydantoin derivatives, intentional self-harm, initial encounter
T42.0X3A
Poisoning by hydantoin derivatives, assault, initial encounter
T42.0X4A
Poisoning by hydantoin derivatives, undetermined, initial encounter
T42.3X1A
Poisoning by barbiturates, accidental (unintentional), initial encounter
T42.3X2A
Poisoning by barbiturates, intentional self-harm, initial encounter
T42.3X3A
Poisoning by barbiturates, assault, initial encounter
T42.3X4A
Poisoning by barbiturates, undetermined, initial encounter
T42.4X1A
Poisoning by benzodiazepines, accidental (unintentional), initial encounter
T42.4X2A
Poisoning by benzodiazepines, intentional self-harm, initial encounter
T42.4X3A
Poisoning by benzodiazepines, assault, initial encounter
T42.4X4A
Poisoning by benzodiazepines, undetermined, initial encounter
T42.6X1A
Poisoning by other antiepileptic and sedative-hypnotic drugs, accidental (unintentional), initial encounter
T42.6X2A
Poisoning by other antiepileptic and sedative-hypnotic drugs, intentional self-harm, initial encounter
T42.6X3A
Poisoning by other antiepileptic and sedative-hypnotic drugs, assault, initial encounter
T42.6X4A
Poisoning by other antiepileptic and sedative-hypnotic drugs, undetermined, initial encounter
T42.71XA
Poisoning by unspecified antiepileptic and sedative-hypnotic drugs, accidental (unintentional), initial encounter
T42.72XA
Poisoning by unspecified antiepileptic and sedative-hypnotic drugs, intentional self-harm, initial encounter
T42.73XA
Poisoning by unspecified antiepileptic and sedative-hypnotic drugs, assault, initial encounter
T42.74XA
Poisoning by unspecified antiepileptic and sedative-hypnotic drugs, undetermined, initial encounter
T43.011A
Poisoning by tricyclic antidepressants, accidental (unintentional), initial encounter
T43.012A
Poisoning by tricyclic antidepressants, intentional self-harm, initial encounter
T43.013A
Poisoning by tricyclic antidepressants, assault, initial encounter
T43.014A
Poisoning by tricyclic antidepressants, undetermined, initial encounter
T43.021A
Poisoning by tetracyclic antidepressants, accidental (unintentional), initial encounter
T43.022A
Poisoning by tetracyclic antidepressants, intentional self-harm, initial encounter
T43.023A
Poisoning by tetracyclic antidepressants, assault, initial encounter
T43.024A
Poisoning by tetracyclic antidepressants, undetermined, initial encounter
T43.1X1A
Poisoning by monoamine-oxidase-inhibitor antidepressants, accidental (unintentional), initial encounter
T43.1X2A
Poisoning by monoamine-oxidase-inhibitor antidepressants, intentional self-harm, initial encounter
T43.1X3A
Poisoning by monoamine-oxidase-inhibitor antidepressants, assault, initial encounter
T43.1X4A
Poisoning by monoamine-oxidase-inhibitor antidepressants, undetermined, initial encounter
T43.201A
Poisoning by unspecified antidepressants, accidental (unintentional), initial encounter
T43.202A
Poisoning by unspecified antidepressants, intentional self-harm, initial encounter
T43.203A
Poisoning by unspecified antidepressants, assault, initial encounter
T43.204A
Poisoning by unspecified antidepressants, undetermined, initial encounter
T43.211A
Poisoning by selective serotonin and norepinephrine reuptake inhibitors, accidental (unintentional), initial encounter
T43.212A
Poisoning by selective serotonin and norepinephrine reuptake inhibitors, intentional self-harm, initial encounter
T43.213A
Poisoning by selective serotonin and norepinephrine reuptake inhibitors, assault, initial encounter
T43.214A
Poisoning by selective serotonin and norepinephrine reuptake inhibitors, undetermined, initial encounter
T43.221A
Poisoning by selective serotonin reuptake inhibitors, accidental (unintentional), initial encounter
T43.222A
Poisoning by selective serotonin reuptake inhibitors, intentional self-harm, initial encounter
T43.223A
Poisoning by selective serotonin reuptake inhibitors, assault, initial encounter
T43.224A
Poisoning by selective serotonin reuptake inhibitors, undetermined, initial encounter
T43.291A
Poisoning by other antidepressants, accidental (unintentional), initial encounter
T43.292A
Poisoning by other antidepressants, intentional self-harm, initial encounter
T43.293A
Poisoning by other antidepressants, assault, initial encounter
T43.294A
Poisoning by other antidepressants, undetermined, initial encounter
T43.3X1A
Poisoning by phenothiazine antipsychotics and neuroleptics, accidental (unintentional), initial encounter
T43.3X2A
Poisoning by phenothiazine antipsychotics and neuroleptics, intentional self-harm, initial encounter
T43.3X3A
Poisoning by phenothiazine antipsychotics and neuroleptics, assault, initial encounter
T43.3X4A
Poisoning by phenothiazine antipsychotics and neuroleptics, undetermined, initial encounter
T43.4X1A
Poisoning by butyrophenone and thiothixene neuroleptics, accidental (unintentional), initial encounter
T43.4X2A
Poisoning by butyrophenone and thiothixene neuroleptics, intentional self-harm, initial encounter
T43.4X3A
Poisoning by butyrophenone and thiothixene neuroleptics, assault, initial encounter
T43.4X4A
Poisoning by butyrophenone and thiothixene neuroleptics, undetermined, initial encounter
T43.501A
Poisoning by unspecified antipsychotics and neuroleptics, accidental (unintentional), initial encounter
T43.502A
Poisoning by unspecified antipsychotics and neuroleptics, intentional self-harm, initial encounter
T43.503A
Poisoning by unspecified antipsychotics and neuroleptics, assault, initial encounter
T43.504A
Poisoning by unspecified antipsychotics and neuroleptics, undetermined, initial encounter
T43.591A
Poisoning by other antipsychotics and neuroleptics, accidental (unintentional), initial encounter
T43.592A
Poisoning by other antipsychotics and neuroleptics, intentional self-harm, initial encounter
T43.593A
Poisoning by other antipsychotics and neuroleptics, assault, initial encounter
T43.594A
Poisoning by other antipsychotics and neuroleptics, undetermined, initial encounter
T43.601A
Poisoning by unspecified psychostimulants, accidental (unintentional), initial encounter
T43.602A
Poisoning by unspecified psychostimulants, intentional self-harm, initial encounter
T43.603A
Poisoning by unspecified psychostimulants, assault, initial encounter
T43.604A
Poisoning by unspecified psychostimulants, undetermined, initial encounter
T43.611A
Poisoning by caffeine, accidental (unintentional), initial encounter
T43.612A
Poisoning by caffeine, intentional self-harm, initial encounter
T43.613A
Poisoning by caffeine, assault, initial encounter
T43.614A
Poisoning by caffeine, undetermined, initial encounter
T43.621A
Poisoning by amphetamines, accidental (unintentional), initial encounter
T43.622A
Poisoning by amphetamines, intentional self-harm, initial encounter
T43.623A
Poisoning by amphetamines, assault, initial encounter
T43.624A
Poisoning by amphetamines, undetermined, initial encounter
T43.631A
Poisoning by methylphenidate, accidental (unintentional), initial encounter
T43.632A
Poisoning by methylphenidate, intentional self-harm, initial encounter
T43.633A
Poisoning by methylphenidate, assault, initial encounter
T43.634A
Poisoning by methylphenidate, undetermined, initial encounter
T43.641A
Poisoning by ecstasy, accidental (unintentional), initial encounter
T43.641D
Poisoning by ecstasy, accidental (unintentional), subsequent encounter
T43.641S
Poisoning by ecstasy, accidental (unintentional), sequela
T43.642A
Poisoning by ecstasy, intentional self-harm, initial encounter
T43.642D
Poisoning by ecstasy, intentional self-harm, subsequent encounter
T43.642S
Poisoning by ecstasy, intentional self-harm, sequela
T43.643A
Poisoning by ecstasy, assault, initial encounter
T43.643D
Poisoning by ecstasy, assault, subsequent encounter
T43.643S
Poisoning by ecstasy, assault, sequela
T43.644A
Poisoning by ecstasy, undetermined, initial encounter
T43.644D
Poisoning by ecstasy, undetermined, subsequent encounter
T43.644S
Poisoning by ecstasy, undetermined, sequela
T43.691A
Poisoning by other psychostimulants, accidental (unintentional), initial encounter
T43.692A
Poisoning by other psychostimulants, intentional self-harm, initial encounter
T43.693A
Poisoning by other psychostimulants, assault, initial encounter
T43.694A
Poisoning by other psychostimulants, undetermined, initial encounter
T43.8X1A
Poisoning by other psychotropic drugs, accidental (unintentional), initial encounter
T43.8X2A
Poisoning by other psychotropic drugs, intentional self-harm, initial encounter
T43.8X3A
Poisoning by other psychotropic drugs, assault, initial encounter
T43.8X4A
Poisoning by other psychotropic drugs, undetermined, initial encounter
T43.91XA
Poisoning by unspecified psychotropic drug, accidental (unintentional), initial encounter
T43.92XA
Poisoning by unspecified psychotropic drug, intentional self-harm, initial encounter
T43.93XA
Poisoning by unspecified psychotropic drug, assault, initial encounter
T43.94XA
Poisoning by unspecified psychotropic drug, undetermined, initial encounter
T45.0X1A
Poisoning by antiallergic and antiemetic drugs, accidental (unintentional), initial encounter
T45.0X2A
Poisoning by antiallergic and antiemetic drugs, intentional self-harm, initial encounter
T45.0X3A
Poisoning by antiallergic and antiemetic drugs, assault, initial encounter
T45.0X4A
Poisoning by antiallergic and antiemetic drugs, undetermined, initial encounter
T46.0X1A
Poisoning by cardiac-stimulant glycosides and drugs of similar action, accidental (unintentional), initial encounter
T46.0X2A
Poisoning by cardiac-stimulant glycosides and drugs of similar action, intentional self-harm, initial encounter
T46.0X3A
Poisoning by cardiac-stimulant glycosides and drugs of similar action, assault, initial encounter
T46.0X4A
Poisoning by cardiac-stimulant glycosides and drugs of similar action, undetermined, initial encounter
T50.901A
Poisoning by unspecified drugs, medicaments and biological substances, accidental (unintentional), initial encounter
T50.902A
Poisoning by unspecified drugs, medicaments and biological substances, intentional self-harm, initial encounter
T50.903A
Poisoning by unspecified drugs, medicaments and biological substances, assault, initial encounter
T50.904A
Poisoning by unspecified drugs, medicaments and biological substances, undetermined, initial encounter
T50.911A
Poisoning by multiple unspecified drugs, medicaments and biological substances, accidental (unintentional), initial encounter
T50.911D
Poisoning by multiple unspecified drugs, medicaments and biological substances, accidental (unintentional), subsequent encounter
T50.911S
Poisoning by multiple unspecified drugs, medicaments and biological substances, accidental (unintentional), sequela
T50.912A
Poisoning by multiple unspecified drugs, medicaments and biological substances, intentional self-harm, initial encounter
T50.912D
Poisoning by multiple unspecified drugs, medicaments and biological substances, intentional self-harm, subsequent encounter
T50.912S
Poisoning by multiple unspecified drugs, medicaments and biological substances, intentional self-harm, sequela
T50.913A
Poisoning by multiple unspecified drugs, medicaments and biological substances, assault, initial encounter
T50.913D
Poisoning by multiple unspecified drugs, medicaments and biological substances, assault, subsequent encounter
T50.913S
Poisoning by multiple unspecified drugs, medicaments and biological substances, assault, sequela
T50.914A
Poisoning by multiple unspecified drugs, medicaments and biological substances, undetermined, initial encounter
T50.914D
Poisoning by multiple unspecified drugs, medicaments and biological substances, undetermined, subsequent encounter
T50.914S
Poisoning by multiple unspecified drugs, medicaments and biological substances, undetermined, sequela
T50.915A
Adverse effect of multiple unspecified drugs, medicaments and biological substances, initial encounter
T50.915D
Adverse effect of multiple unspecified drugs, medicaments and biological substances, subsequent encounter
T50.915S
Adverse effect of multiple unspecified drugs, medicaments and biological substances, sequela
T50.916A
Underdosing of multiple unspecified drugs, medicaments and biological substances, initial encounter
T50.916D
Underdosing of multiple unspecified drugs, medicaments and biological substances, subsequent encounter
T50.916S
Underdosing of multiple unspecified drugs, medicaments and biological substances, sequela
Z51.81
Encounter for therapeutic drug level monitoring
Z79.3
Long term (current) use of hormonal contraceptives
Z79.891
Long term (current) use of opiate analgesic
Z79.899
Other long term (current) drug therapy
Z91.190
Patient's noncompliance with other medical treatment and regimen due to financial hardship
Z91.198
Patient's noncompliance with other medical treatment and regimen for other reason
Z91.199
Patient's noncompliance with other medical treatment and regimen due to unspecified reason
Z91.A10
Caregiver's noncompliance with patient's dietary regimen due to financial hardship
Z91.A18
Caregiver's noncompliance with patient's dietary regimen for other reason
Z91.A20
Caregiver's intentional underdosing of patient's medication regimen due to financial hardship
Z91.A28
Caregiver's intentional underdosing of medication regimen for other reason
Z91.A3
Caregiver's unintentional underdosing of patient's medication regimen
Z91.A41
Caregiver's other noncompliance with patient's medication regimen due to financial hardship
Z91.A48
Caregiver's other noncompliance with patient's medication regimen for other reason
Z91.A51
Caregiver's noncompliance with patient's renal dialysis due to financial hardship
Z91.A58
Caregiver's noncompliance with patient's renal dialysis for other reason
Z91.A91
Caregiver's noncompliance with patient's other medical treatment and regimen due to financial hardship
Z91.A98
Caregiver's noncompliance with patient's other medical treatment and regimen for other reason
ICD-10 Codes That Are Not Covered
N/A
Revision History Information
Revision History Date
Revision History Number
Revision History Explanation
10/01/2024
R22
Revision Effective Date: 10/01/2024 ICD-10-CM CODES THAT SUPPORT MEDICAL NECESSITY: Deleted: ICD-10-CM codes M51.36, M51.37 from Group 1 Codes
10/01/2024: At this time 21st Century Cures Act applies to new and revised LCDs which require comment and notice. This revision is to an article that is not a local coverage determination. This revision is due to the 2024 Annual ICD-10 updates.
10/08/2023
R21
Updated to indicate this article is an LCD Reference Article.
10/08/2023
R20
Revision History R18 should have also included the following:
Under ICD-10 Codes that support Medical Necessity Group 1 Codes added: E87.20 and deleted: F11.21, F12.20, F15.20, F19.10, F19.14, M25.59, M54.50, M54.59, Z91.141, Z91.148, Z91.151, Z91.158.
These updates are effective 10/08/2023.
The following ICD-10 Codes were previously mentioned as deleted in R18 but were listed incorrectly: F10.21, F10.230, F10.280, F10.288. They were not deleted as they were not in the policy.
Revision History R19 should have indicated the ICD-10 Annual Updates were effective 10/01/2023.
10/08/2023
R19
Per ICD-10 Annual updates:
The following codes were added to Group 1: I47.10, I47.11, I47.19, R40.2A, Z91.A41, Z91.A48, Z91.A51, Z91.A58, Z91.A91, Z91.A98
The following codes were deleted from Group 1: I47.1, Z91.A4, Z91.A5, Z91.A9
10/08/2023
R18
Under Article title revised title to read Billing and Coding: Urine Drug Testing. Under Article Text section deleted all verbiage after first sentence and added new coding guidelines verbiage. Under CPT/HCPCS Codes Group 1: Paragraph deleted entire sentence. Under CPT/HCPCS Codes Group 1: Codes deleted 0328U and 0227U. Under ICD-10 Codes that Support Medical Necessity Group 1: Codes added F11.229, F11.259, F11.29, G40.901, G40.909, G40.911, G40.919, M25.50, M54.51, M54.9, M60.9, M79.10, M79.11, M79.12, M79.18, R40.20, T14.91XA, T14.91XD, T14.91XS, T50.911A, T50.911D, T50.911S, T50.912A, T50.912D, T50.912S, T50.913A, T50.913D, T50.913S, T50.914A, T50.914D, T50.914S, T50.915A, T50.915D, T50.915S, T50.916A, T50.916D, T50.916S, Z91.A10, Z91.A18, Z91.A20, Z91.A28, Z91.A3, Z91.A4, Z91.A5, Z91.A9 and deleted F10.130, F10.131, F10.132, F10.21, F10.230, F10.280, F10.288, F11.13, F12.13, F12.23, F12.93, F13.130, F13.131, F13.132, F14.13, F14.93, F15.13, F19.130, F19.131, F19.132, G40.42, M25.511, M25.512, M54.10, M54.12, R41.82, R45.850, R45.851, R45.88, T40.411A, T40.411D, T40.411S, T40.412A, T40.412D, T40.412S, T40.413A, T40.413D, T40.413S, T40.414A, T40.414D, T40.414S, T40.421A, T40.421D, T40.421S, T40.422A, T40.422D, T40.422S, T40.423A, T40.423D, T40.423S, T40.424A, T40.424D, T40.424S, T40.491D, T40.491S, T40.492D, T40.492S, T40.493D, T40.493S, T40.494D, T40.494S, T40.711D, T40.711S, T40.712D, T40.712S, T40.713D, T40.713S, T40.714D, T40.714S, T40.721A, T40.721D, T40.721S, T40.722A, T40.722D, T40.722S, T40.723A, T40.723D, T40.723S, T40.724A, T40.724D, T40.724S, T43.651A, T43.651D, T43.651S, T43.652A, T43.652D, T43.652S, T43.653A, T43.653D, T43.653S, T43.654A, T43.654D, T43.654S, T43.655A, T43.655D, T43.655S, T43.656A, T43.656D, T43.656S, Z03.821, Z03.822, Z03.823, Z03.89.
07/01/2023
R17
Under CPT/HCPCS Group 1 Codes, removed codes 0143U, 0144U, 0145U, 0146U, 0147U, 0148U, 0149U and 0150U per Q3 2023 CPT/HCPCS Updates.
04/01/2023
R16
Under Group 1: ICD-10 Codes That Support Medical Necessity, added Z91.141, Z91.148, Z91.151, Z91.158 effective 04/01/2023.
10/01/2022
R15
Under Group 1: ICD-10 Codes That Support Medical Necessity, added Z91.198 and Z91.199 effective 10/01/2022.
10/01/2022
R14
Under Group 1: ICD-10 Codes That Support Medical Necessity, added F11.21, F12.20, F15.20, F19.10, F19.14 effective 01/01/2022.
10/01/2022
R13
Effective 10/01/2022 - Annual ICD-10 Updates:
The following ICD-10 codes were deleted from Group 1:
Under Group 1: ICD-10-Codes that Support Medical Necessity added M54.50, M54.51, M54.59. This revision is effective 10/01/2021.
10/01/2021
R11
Under ICD-10 Codes that Support Medical Necessity Group 1: Codes deleted M54.5,T40.7X1A,T40.7X2A, T40.7X3A, T40.7X4A and added R45.88, T40.711A, T40.711D, T40.711S, T40.712A, T40.712D, T40.712S, T40.713A, T40.713D, T40.713S, T40.714A, T40.714D, T40.714S, T40.721A, T40.721D, T40.721S, T40.722A, T40.722D, T40.722S, T40.723A, T40.723D, T40.723S, T40.724A, T40.724D, T40.724S. This revision is due to the Annual ICD-10 update and is effective on 10/1/21.
01/01/2021
R10
Under ICD-10 Codes that Support Medical Necessity – Group 1: Codes deleted codes F11.229, F11.259, F11.29, G40.901, G40.909, G40.911, G40.919, M25.50, M60.9 and R40.20. This revision is effective on 10/1/20.
01/01/2021
R9
Under CMS National Coverage Policy added the regulation for CMS Internet-Only Manual, Pub. 100-02, Medicare Benefit Policy Manual, Chapter 15, §80.1.2 - A/B MAC (B) Contacts with Independent Clinical Laboratories to this section. This revision has a retroactive effective date of 1/1/21.
Under CPT/HCPCS Codes Group 1: Codes added code 0227U due to the Q1 2021 CPT/HCPCS code update and has a retroactive effective date of 1/1/21.
10/01/2020
R8
Under ICD-10 Codes that Support Medical Necessity – Group 1: Codes added codes F10.130, F10.131, F10.132, F11.13, F12.13, F13.130, F13.131, F13.132, F14.13, F14.93, F15.13, F19.130, F19.131, F19.132, G40.42, T40.411A, T40.411D, T40.411S, T40.412A, T40.412D, T40.412S, T40.413A, T40.413D, T40.413S, T40.414A, T40.414D, T40.414S, T40.421A, T40.421D, T40.421S, T40.422A, T40.422D, T40.422S, T40.423A, T40.423D, T40.423S, T40.424A, T40.424D, T40.424S, T40.491A, T40.491D, T40.491S, T40.492A, T40.492D, T40.492S, T40.493A, T40.493D, T40.493S, T40.494A, T40.494D, T40.494S, Z03.821, Z03.822, Z03.823 and deleted codes T40.4X1A, T40.4X2A, T40.4X3A, and T40.4X4A. This revision is due to the Annual ICD-10 Code Update and is effective on 10/1/20.
Under ICD-10 Codes that Support Medical Necessity – Group 1: Codes deleted codes F11.229, F11.259, F11.29, G40.901, G40.909, G40.911, G40.919, M25.50, M60.9 and R40.20. This revision is effective on 10/1/20.
01/01/2020
R7
01/01/2020: Under CPT/HCPCS Codes Group 1: Codes added HCPCS codes 0143U, 0144U, 0145U, 0146U, 0147U, 0148U, 0149U, 0150U. This revision is due to the Annual CPT®/HCPCS Code Update and becomes effective on 1/1/2020.
This article is being revised in order to adhere to CMS requirements per chapter 13, section 13.5.1 of the Program Integrity Manual.
10/01/2019
R6
10/01/2019: This article is being revised in order to adhere to CMS requirements per chapter 13, section 13.5.1 of the Program Integrity Manual.
Title XVIII of the Social Security Act, §1833(e) was removed from the CMS National Coverage Policy section of the related Lab: Controlled Substance Monitoring and Drugs of Abuse Testing L36668 LCD and placed in this article.
10/01/2019
R5
Added the word "Testing" at the end of the title.
In the Article Text, added the word "Testing" at the end of the sentence.
10/01/2019
R4
All coding located in the Coding Information section has been removed from the related Lab: Controlled Substance Monitoring and Drugs of Abuse Testing L3668 LCD and added to this article.
Under Article Title changed the title from the related "Billing and Coding: 2018 Controlled Substance Monitoring and Drugs of Abuse Coding and Billing Guidelines" to "Billing and Coding: Lab: Controlled Substance Monitoring and Drugs of Abuse Testing". Under Article Text added the sentence "The information in this article contains billing, coding, or other guidelines that complement the Local Coverage Determination (LCD) for Lab: Controlled Substance Monitoring and Drugs of Abuse Testing L36668" for the first paragraph and added the last paragraph. Formatting, punctuation and typographical errors were corrected throughout the article.
01/01/2017
R3
05/15/2018: Change of year in title to 2018.
01/01/2017
R2
03/30/2017 - Under "Presumptive Urine Drug Testing (UDT) " corrected the types of presumptive UDT available per patient DOS from four to three. Under "Definitive (Qualitative or Quantitative) UDT Testing" corrected the number of UDT services per patient DOS from four to five.
01/01/2017
R1
Added the reminder sentence for DOS. Changed the first sentence under Presumptive Urine Drug Testing (UDT); to read "...four types of presumptive UDT..." instead of three. Added new 2017 CPT/HCPCS codes, replaced 2016 with 2017 and replaced “encounter” with DOS. Deleted G0477, G0478 and G0479 under Presumptive Urine Drug Testing topic; Added G0659, 80305, 80306 and 80307; Replaced the word "encounter" with DOS.